Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

414 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiomatoid fibrosis histiocytoma in the pulmonary artery: A case report.
Mishima S, Mishima O, Azuhata K, Shimojo H, Ito N, Misawa K, Shimizu K. Mishima S, et al. Among authors: mishima o. Thorac Cancer. 2021 May;12(9):1453-1456. doi: 10.1111/1759-7714.13929. Epub 2021 Mar 13. Thorac Cancer. 2021. PMID: 33713576 Free PMC article.
Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in size.
Koike S, Shimizu K, Ide S, Mishima S, Matsuoka S, Takeda T, Miura K, Eguchi T, Hamanaka K, Araki T, Sonehara K, Todoroki K, Ichinohe F, Kawakami S, Koinuma M. Koike S, et al. Among authors: mishima s. Thorac Cancer. 2022 Nov;13(21):3018-3024. doi: 10.1111/1759-7714.14653. Epub 2022 Oct 3. Thorac Cancer. 2022. PMID: 36193574 Free PMC article.
Anatomical resection for right B3 downwards-shifting malformation.
Miura K, Shimizu K, Mishima S, Matsuoka S, Eguchi T, Hamanaka K. Miura K, et al. Among authors: mishima s. Gen Thorac Cardiovasc Surg. 2023 Jan;71(1):71-75. doi: 10.1007/s11748-022-01884-6. Epub 2022 Oct 27. Gen Thorac Cardiovasc Surg. 2023. PMID: 36301486
Erratum: Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers.
Chinsuwan T, Hirabayashi K, Mishima S, Hasegawa A, Tanaka M, Mochizuki H, Shimoi A, Murakami T, Yagyu S, Shimizu K, Nakazawa Y. Chinsuwan T, et al. Among authors: mishima s. Mol Ther Oncolytics. 2023 Oct 11;31:100735. doi: 10.1016/j.omto.2023.100735. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 37860015 Free PMC article.
414 results